Comparability of whole-blood and plasma clozapine and norclozapine concentrations.
作者信息
Flanagan R J, Yusufi B, Barnes T R E
出版信息
Br J Clin Pharmacol. 2003 Jul;56(1):135-8. doi: 10.1046/j.1365-2125.2003.01821.x.
Abstract
摘要
相似文献
1
Comparability of whole-blood and plasma clozapine and norclozapine concentrations.全血与血浆中氯氮平及去甲氯氮平浓度的可比性。
Br J Clin Pharmacol. 2003 Jul;56(1):135-8. doi: 10.1046/j.1365-2125.2003.01821.x.
2
Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa).死后变化对家猪（Sus scrofa）外周血和全血以及组织中氯氮平和去甲氯氮平浓度的影响。
Forensic Sci Int. 2003 Mar 12;132(1):9-17. doi: 10.1016/s0379-0738(02)00414-0.
3
Clozapine and Norclozapine Concentrations in Paired Human Plasma and Serum Samples.配对的人血浆和血清样本中氯氮平和去甲氯氮平的浓度。
Ther Drug Monit. 2018 Feb;40(1):148-150. doi: 10.1097/FTD.0000000000000478.
4
Solid-phase extraction and high-performance liquid chromatographic analysis of clozapine and norclozapine in human plasma.人血浆中氯氮平与去甲氯氮平的固相萃取及高效液相色谱分析
Ther Drug Monit. 1996 Dec;18(6):688-92. doi: 10.1097/00007691-199612000-00010.
5
Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007.血浆氯氮平、去甲氯氮平和氯氮平：去甲氯氮平比值与处方剂量及其他因素的关系：1993-2007 年治疗药物监测服务的数据。
Ther Drug Monit. 2010 Aug;32(4):438-47. doi: 10.1097/FTD.0b013e3181dad1fb.
6
Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients.墨西哥精神分裂症患者中氯氮平和去甲氯氮平的血浆水平。
Arzneimittelforschung. 2011;61(6):335-9. doi: 10.1055/s-0031-1296207.
7
Suspected clozapine poisoning in the UK/Eire, 1992-2003.1992年至2003年英国/爱尔兰疑似氯氮平中毒事件
Forensic Sci Int. 2005 Dec 20;155(2-3):91-9. doi: 10.1016/j.forsciint.2004.10.024. Epub 2004 Dec 25.
8
Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients.耐药性精神分裂症患者的临床结局以及氯氮平和去甲氯氮平的血浆水平
Schizophr Res. 2004 Feb 1;66(2-3):197-8. doi: 10.1016/s0920-9964(03)00159-2.
9
Measurement of Clozapine, Norclozapine, and Amisulpride in Plasma and in Oral Fluid Obtained Using 2 Different Sampling Systems.使用两种不同采样系统获取的血浆和口腔液中氯氮平、去甲氯氮平和氨磺必利的测定。
Ther Drug Monit. 2017 Apr;39(2):109-117. doi: 10.1097/FTD.0000000000000377.
10
Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.精神分裂症患者血清和血浆样本中氯氮平和去甲氯氮平的浓度。
Ther Drug Monit. 2008 Feb;30(1):41-5. doi: 10.1097/FTD.0b013e31815f4e72.
引用本文的文献
1
Population Pharmacokinetics of Clozapine: A Systematic Review.氯氮平的群体药代动力学：系统评价。
Biomed Res Int. 2020 Jan 7;2020:9872936. doi: 10.1155/2020/9872936. eCollection 2020.
2
Population Pharmacokinetics of Clozapine and Norclozapine and Switchability Assessment between Brands in Uruguayan Patients with Schizophrenia.氯氮平和去甲氯氮平在精神分裂症乌拉圭患者中的群体药代动力学及品牌间可转换性评估。
Biomed Res Int. 2019 Mar 6;2019:3163502. doi: 10.1155/2019/3163502. eCollection 2019.
3
The Role of Microsystems Integration Towards Point-of-Care Clozapine Treatment Monitoring in Schizophrenia.微系统集成在精神分裂症患者氯氮平治疗即时监测中的作用
IEEE Sens Lett. 2018 Mar;2(1). doi: 10.1109/LSENS.2017.2782883. Epub 2017 Dec 13.
4
The Binding Effect of Proteins on Medications and Its Impact on Electrochemical Sensing: Antipsychotic Clozapine as a Case Study.蛋白质对药物的结合作用及其对电化学传感的影响：以抗精神病药物氯氮平为例的研究
Pharmaceuticals (Basel). 2017 Aug 1;10(3):69. doi: 10.3390/ph10030069.
5
Reliable clinical serum analysis with reusable electrochemical sensor: Toward point-of-care measurement of the antipsychotic medication clozapine.基于可重复使用电化学传感器的可靠临床血清分析：迈向抗精神病药物氯氮平的即时检测
Biosens Bioelectron. 2017 Sep 15;95:55-59. doi: 10.1016/j.bios.2017.04.008. Epub 2017 Apr 12.
6
Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.中国精神分裂症患者氯氮平和其主要代谢物去甲氯氮平的群体药代动力学。
Acta Pharmacol Sin. 2012 Nov;33(11):1409-16. doi: 10.1038/aps.2012.71. Epub 2012 Jul 23.
7
Atypical antipsychotics as noncompetitive inhibitors of alpha4beta2 and alpha7 neuronal nicotinic receptors.非典型抗精神病药作为 alpha4beta2 和 alpha7 神经元烟碱型受体的非竞争性抑制剂。
Neuropharmacology. 2009 Aug;57(2):183-91. doi: 10.1016/j.neuropharm.2009.05.003. Epub 2009 May 28.
本文引用的文献
1
Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients.剂量、吸烟、年龄、性别和代谢活性对血浆氯氮平浓度的影响：一个预测模型和列线图，以辅助氯氮平剂量调整并评估个体患者的依从性。
J Clin Psychopharmacol. 2004 Feb;24(1):70-8. doi: 10.1097/01.jcp.0000106221.36344.4d.
2
Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa).死后变化对家猪（Sus scrofa）外周血和全血以及组织中氯氮平和去甲氯氮平浓度的影响。
Forensic Sci Int. 2003 Mar 12;132(1):9-17. doi: 10.1016/s0379-0738(02)00414-0.
3
Human alpha-1-glycoprotein and its interactions with drugs.人α-1-糖蛋白及其与药物的相互作用。
Drug Metab Rev. 2001 May;33(2):161-235. doi: 10.1081/dmr-100104402.
4
Alpha-1-acid glycoprotein.α-1-酸性糖蛋白
Biochim Biophys Acta. 2000 Oct 18;1482(1-2):157-71. doi: 10.1016/s0167-4838(00)00153-9.
5
Therapeutic drug monitoring of clozapine: an unexpected outcome.氯氮平的治疗药物监测：一个意外结果。
Ther Drug Monit. 2000 Jun;22(3):323-4. doi: 10.1097/00007691-200006000-00015.
6
Clozapine monitoring: plasma or serum levels?氯氮平监测：血浆还是血清水平？
Ther Drug Monit. 1999 Jun;21(3):327-9. doi: 10.1097/00007691-199906000-00014.
7
Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance.氯氮平及其代谢产物在精神科患者中的药代动力学：血浆蛋白结合与肾脏清除率。
Br J Clin Pharmacol. 1998 Nov;46(5):453-9. doi: 10.1046/j.1365-2125.1998.00822.x.
8
Determination of clozapine and its major metabolites in human plasma and red blood cells by high-performance liquid chromatography with ultraviolet absorbance detection.采用高效液相色谱-紫外吸收检测法测定人血浆和红细胞中的氯氮平及其主要代谢物。
J Chromatogr B Biomed Sci Appl. 1997 Mar 7;690(1-2):211-22. doi: 10.1016/s0378-4347(96)00362-3.
9
Clozapine plasma level monitoring: current status.氯氮平血药浓度监测：现状
Psychiatr Q. 1996 Winter;67(4):297-311. doi: 10.1007/BF02326373.
10
The clinical use of clozapine plasma concentrations in the management of treatment-refractory schizophrenia.氯氮平血药浓度在难治性精神分裂症治疗管理中的临床应用。
Ann Clin Psychiatry. 1996 Jun;8(2):99-109. doi: 10.3109/10401239609148808.
Zotero 插件